By Janyce McGregor, CBC News, December 1, 2016
CETA drug-patent extension applies only to new products, and higher costs are likely at least 8 years away
Are the benefits of Canada’s free trade agreement with Europe worth what it costs? New Democrat Tracey Ramsey is trying to do the math.
In questioning witnesses from the generic pharmaceutical industry at the Commons international trade committee Tuesday, Ramsey compared two figures that seemed to cancel each other out.